NovoCure (NVCR) Common Equity (2014 - 2026)
NovoCure (NVCR) posted Common Equity of $338.1 million for Q2 2026, up 2.23% sequentially from $330.7 million in Q1 2026, and down 3.25% YoY from $349.4 million in Q2 2025.
NovoCure (NVCR) Common Equity (2014 - 2026) Analysis & Trends
NovoCure has reported Common Equity for 13 years, with the latest figure at $338.1 million in Q2 2026.
- Quarterly Common Equity fell 3.25% year-over-year to $338.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $338.1 million (down 3.25% YoY) and the FY2025 annual result came in at $340.5 million, down 5.47% from the prior year.
- Common Equity grew to $338.1 million in Q2 2026 per NVCR's latest filing, from $330.7 million in the prior quarter.
- Over five years, Common Equity peaked at $445.4 million in Q3 2022 and troughed at $330.7 million in Q1 2026.
- A 5-year average of $381.8 million and a median of $361.9 million in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2023: Common Equity gained 17.13% in 2022, then retreated 17.83% in 2023.
- Over 5 years, Common Equity stood at $441.2 million in 2022, then dropped by 17.83% to $362.5 million in 2023, then slipped by 0.64% to $360.2 million in 2024, then declined by 5.47% to $340.5 million in 2025, then decreased by 0.7% to $338.1 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $338.1 million, $330.7 million, and $340.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | 338.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 338.09 Mn |
| Mar 31, 2026 | 330.72 Mn |
| Dec 31, 2025 | 340.47 Mn |
| Sep 30, 2025 | 341.33 Mn |
| Jun 30, 2025 | 349.44 Mn |
| Mar 31, 2025 | 361.96 Mn |
| Dec 31, 2024 | 360.18 Mn |
| Sep 30, 2024 | 360.78 Mn |
| Jun 30, 2024 | 361.75 Mn |
| Mar 31, 2024 | 359.36 Mn |
| Dec 31, 2023 | 362.50 Mn |
| Sep 30, 2023 | 393.70 Mn |
| Jun 30, 2023 | 415.68 Mn |
| Mar 31, 2023 | 432.15 Mn |
| Dec 31, 2022 | 441.17 Mn |
| Sep 30, 2022 | 445.40 Mn |
| Jun 30, 2022 | 441.67 Mn |
| Mar 31, 2022 | 435.88 Mn |
| Dec 31, 2021 | 410.49 Mn |
| Sep 30, 2021 | 413.16 Mn |